표재성 방광암의 BCG 방광내 주입요법: 예보(I)

Abstract

Tice-Chicago strain bacillus Calmette-Guerin was used to treat superficial transitional cell carcinoma of the bladder in 11 patients. The treatment regimen of 120mg. Tice-Chicago strain bacillus Calmette-Guerin weekly for 6 weeks and then monthly for 3 months was well tolerated. Side effects during or shortly after treatment were minor and self-limiting in the majority of patients (fever, bladder irritability and hematuria). Although the findings are still preliminary, they appear to hold promise of a new therapeutic approach to the treatment of a group of carcinoma of the bladder for which effective therapy is still lacking in this country.